Additionally, it is crucial to treat MMFTC tumors as aggressive variants and monitor patients closely with neck ultrasounds and tumor markers (calcitonin, thyroglobulin, CEA) to detect early signs of recurrence and improve survival. Here, CALCA is linked to neoplasm.